|
|
Volumn 2013, Issue , 2013, Pages 95-102
|
|
EBV and posttransplantation lymphoproliferative disease: what to do?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
MONOCLONAL ANTIBODY;
PREDNISONE;
RITUXIMAB;
VINCRISTINE;
ADOPTIVE IMMUNOTHERAPY;
ADULT;
ALLOGRAFT;
CLINICAL TRIAL (TOPIC);
CYTOTOXIC T LYMPHOCYTE;
EPSTEIN BARR VIRUS;
EPSTEIN-BARR VIRUS INFECTIONS;
FEMALE;
HUMAN;
LYMPHOPROLIFERATIVE DISORDERS;
MALE;
ORGAN TRANSPLANTATION;
PROCEDURES;
RADIOTHERAPY;
REMISSION;
TIME;
TRANSPLANTATION;
VIROLOGY;
ADULT;
ALLOGRAFTS;
ANTIBODIES, MONOCLONAL, MURINE-DERIVED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS AS TOPIC;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EPSTEIN-BARR VIRUS INFECTIONS;
FEMALE;
HERPESVIRUS 4, HUMAN;
HUMANS;
IMMUNOTHERAPY, ADOPTIVE;
LYMPHOPROLIFERATIVE DISORDERS;
MALE;
ORGAN TRANSPLANTATION;
PREDNISONE;
RADIOTHERAPY;
REMISSION INDUCTION;
T-LYMPHOCYTES, CYTOTOXIC;
TIME FACTORS;
VINCRISTINE;
|
|
EID: 84901320542
PISSN: None
EISSN: 15204383
Source Type: Journal
DOI: 10.1182/asheducation-2013.1.95 Document Type: Article |
|
Times cited : (39)
|
|
References (0)
|